Headquartered in North Chicago, Illinois, AbbVie US offers exciting
opportunities to develop and market advanced therapies and solutions
to address some of the world’s most complex and serious diseases.
North Chicago is also home to our R&D Centre of Excellence and our
Operations and Commercial teams. The variety of roles available are
endless—from analysts and scientists to strategists and marketeers.
AbbVie is expanding its oncology hub on the West Coast, with three
sites in the San Francisco Bay Area (Redwood City, South San Francisco
and Sunnyvale) focused on the discovery and development of novel
oncology therapies. More than 1,000 AbbVie scientists, clinicians and
product developers with strong entrepreneurial roots work across these
three sites. They combine their expertise in immuno-oncology, stem
cells and cell-signaling with their knowledge of bispecific
antibodies, antibody-drug conjugates (ADCs) and covalent-inhibitor
technologies to discover and develop novel cancer treatments.
AbbVie also has a hub in Massachusetts employing nearly 900 in the
state. The AbbVie Bioresearch Centre in Worcester, Massachusetts is
home to biologics and immunology discovery, as well as biologics
development and manufacturing. In 2016, we opened the
43,000-square-foot Foundational Neuroscience Center (FNC) in the
Cambridge, Massachusetts biotech corridor; there, we are researching
the biological mechanisms underlying neurodegenerative diseases.